Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALStandard

FEMRING

ESTRADIOL ACETATE

Standard Dose
EQ 0.05MG BASE/24HR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FEMRING is listed in Drugs@FDA under application 021367 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL ACETATE Form and strength INSERT, EXTENDED RELEASE;VAGINAL - EQ 0.05MG BASE/24HR Sponsor MILLICENT MFG PR Submission history Latest submission status date: 2024-02-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview FEMRING is listed in Drugs@FDA under application 021367 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL ACETATE Form and strength INSERT, EXTENDED RELEASE;VAGINAL - EQ 0.05MG BASE/24HR Sponsor MILLICENT MFG PR Submission history Latest submission status date: 2024-02-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.